Prenylated flavonoid morusin protects against TNBS-induced colitis in rats.

ABSTRACT: Morusin is a prenylated flavonoid isolated from the root bark of Morus alba. Many studies have shown the ability of flavonoids to act as anti-inflammatory agents. The aim of this study was to evaluate the effect of morusin on experimentally colitis induced by 2,4,6-trinitrobenzensulfonic acid in Wistar rats and to compare it with sulfasalazine, a drug conventionally used in the treatment of inflammatory bowel disease. Morusin was administered by gavage at doses of 12.5, 25, or 50 mg/kg/day for five days. The colonic tissue was evaluated macroscopically, histologically, and by performing immunodetection and zymographic analysis to determine the levels of antioxidant enzymes [superoxide dismutase (SOD) and catalase (CAT)], interleukin (IL)-1?, and transforming growth factor (TGF)-?1 and the activities of matrix metalloproteinases (MMP) 2 and 9. The tissue damage scores were significantly reduced with increasing dose of morusin, however efficacy was not demonstrated at the highest dose. At the dose of 12.5 mg/kg, morusin exerted therapeutic effectivity similar to that of sulfasalazine (50 mg/kg). This was associated with significant reduction of TGF-?1 levels and MMP2 and MMP9 activities, and slight reduction of IL-1?. Our results suggest that morusin possesses therapeutic potential for the treatment of chronic inflammatory diseases.

SUBMITTER: Vochyanova Z 

PROVIDER: S-EPMC5552281 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature